Sign in

NCT07337590Recruiting

Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar

Source: ClinicalTrials.gov · Last updated 16 Jun 2026

Brief summary (registry, in English)

Purpose: To evaluate the effect of xBar system utilization on clinical outcomes during recovery following colorectal surgery.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
80 (estimated)
First submitted
5 Dec 2025
Start date
10 Mar 2026
Primary completion date
31 Dec 2027
Lead sponsor
Exero Medical Ltd.
NCT number
NCT07337590

What you commit to

  • Study type: Interventional
  • Planned participants: 80
  • From 10 Mar 2026 to the primary completion date, 31 Dec 2027
  • 6 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Contraindication for surgery and/or general anesthesia.
  • Subjects receiving prophylactic stoma formation during index surgery (to be confirmed intraoperatively)

Other illness

  • Subjects with benign disease
  • Major medical or psychiatric illness or condition, or other factors that may affect general health or ability to adhere to the follow-up schedule.
  • Known allergic reactions to materials used in the components of the xBar system, i.e., silicone, rubber and stainless-steel.
  • Participation in another interventional study during the xBar system usage. Historical Cohort
    • 1\. LAR performed for benign or non-oncologic indications (e.g., diverticulitis, inflammatory bowel disease, non-malignant strictures, fistula).

Other

  • Interventional Cohort
  • Known pregnancy or lactation.
  • Known electronic devices implanted in the chest or the abdominal cavity (e.g., pacemaker, cardioverter/defibrillator).

Who the study is looking for

  • Interventional Cohort
  • Adults (≥21 years) scheduled for elective low anterior resection (by any surgical technique), due to colorectal cancer
  • Expected anastomosis within 10 cm from the anal verge
  • Usage of drain during the surgery (to be confirmed during the surgery)
  • Willing and able to comply with the study follow up and able and agree to provide informed consent.
    • Historical Cohort
  • Adults aged ≥21 years at the time of surgery.
  • Underwent a low anterior resection (LAR) for malignant colorectal disease.
  • Documented colorectal anastomosis located \<10cm from the anal verge, or documented tumor \<10cm from the anal verge. Complete documentation for the index hospitalization and for the required 12-month follow-up period, or up to stoma take down procedure whichever came first.

Age in the registry: 21 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (6)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Johns Hopkins University
Coordinator of this site? Confirm its status
BaltimoreUnited StatesRecruiting
Bryan Medical Center
Coordinator of this site? Confirm its status
LincolnUnited StatesRecruiting
University of Louisville Hospital
Coordinator of this site? Confirm its status
LouisvilleUnited StatesRecruiting
Department of Colon and Rectal Surgery
Coordinator of this site? Confirm its status
New YorkUnited StatesNot yet recruiting
Weill Cornell Medicine Colon and Rectal Surgery
Coordinator of this site? Confirm its status
New YorkUnited StatesRecruiting
Allegheny Health Network
Coordinator of this site? Confirm its status
PittsburghUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.